Literature DB >> 3410814

Cerebrospinal fluid indoleacetic acid in autistic subjects.

G M Anderson1, D L Ross, W Klykylo, F C Feibel, D J Cohen.   

Abstract

Cerebrospinal fluid (CSF) levels of the tryptamine metabolite, indoleacetic acid (IAA), have been measured in groups of autistic and control subjects. No significant difference was seen in group mean (+/- SEM) levels of CSF IAA (autistics 5.53 +/- 0.47 ng/ml, N = 10). The finding indicates that central metabolism of the behaviorally active trace amine tryptamine is probably normal in autism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410814     DOI: 10.1007/bf02211951

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  10 in total

1.  The subcellular distribution of beta-phenylethylamine, p-tyramine and tryptamine in rat brain.

Authors:  A A Boulton; G B Baker
Journal:  J Neurochem       Date:  1975-10       Impact factor: 5.372

2.  Identification and distribution of tryptamine in the rat.

Authors:  S R Philips; D A Durden; A A Boulton
Journal:  Can J Biochem       Date:  1974-06

3.  The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid.

Authors:  S N Young; G M Anderson; S Gauthier; W C Purdy
Journal:  J Neurochem       Date:  1980-05       Impact factor: 5.372

4.  Tryptamine and 5-hydroxytryptamine: actions and interactions of cortical neurones in the rat.

Authors:  R S Jones; A A Boulton
Journal:  Life Sci       Date:  1980-11-17       Impact factor: 5.037

5.  Liquid chromatographic-fluorometric system for the determination of indoles in physiological samples.

Authors:  G M Anderson; W C Purdy
Journal:  Anal Chem       Date:  1979-02       Impact factor: 6.986

6.  Gas chromatography--mass fragmentographic determination of indole-3-acetic acid in rat brain.

Authors:  J J Warsh; P W Chan; D D Godse; D V Coscina; H C Stancer
Journal:  J Neurochem       Date:  1977-12       Impact factor: 5.372

7.  Neurotransmitter precursors and metabolites in CSF of human neonates.

Authors:  G M Anderson; E L Hoder; B A Shaywitz; D J Cohen
Journal:  Dev Med Child Neurol       Date:  1985-04       Impact factor: 5.449

8.  Tryptamine: a neuromodulator or neurotransmitter in mammalian brain?

Authors:  R S Jones
Journal:  Prog Neurobiol       Date:  1982       Impact factor: 11.685

Review 9.  Clinical neurochemistry of autism and associated disorders.

Authors:  J G Young; M E Kavanagh; G M Anderson; B A Shaywitz; D J Cohen
Journal:  J Autism Dev Disord       Date:  1982-06

10.  Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indoleacetic acid in cerebrospinal fluid.

Authors:  G M Anderson; R H Gerner; D J Cohen; L Fairbanks
Journal:  Biol Psychiatry       Date:  1984-10       Impact factor: 13.382

  10 in total
  3 in total

1.  Childhood autism: An appeal for an integrative and psychobiological approach.

Authors:  Robert D Oades; Christian Eggers
Journal:  Eur Child Adolesc Psychiatry       Date:  1994-07       Impact factor: 4.785

Review 2.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

Review 3.  Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.

Authors:  Guillermo Gervasini; Juan Antonio Carrillo; Julio Benitez
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.